Amenable Treatable Severe Pediatric Epilepsies

Area of Science:

• Pediatric Neurology
• Metabolic Disorders
• Epilepsy Management

Background:

• Severe pediatric epilepsies often stem from underlying metabolic disorders.
• Conditions like vitamin-dependent epilepsies present diverse phenotypes, including early-onset epileptic encephalopathies and infantile spasms.
• These disorders can manifest across various age groups, from infancy to adulthood.

Purpose of the Study:

• To highlight treatable pediatric epilepsies caused by metabolic derangements.
• To emphasize the importance of early identification, testing, and treatment for improving disease course.
• To provide an overview of various metabolic epilepsies and their specific interventions.

Main Methods:

• Review of vitamin-responsive epilepsies (pyridoxine, folinic acid, biotin).
• Categorization of transportopathies (e.g., GLUT-1 deficiency, cerebral folate deficiency).
• Discussion of amino and organic acidopathies, mitochondrial disorders, urea cycle defects, neurotransmitter deficiencies, and glucose homeostasis disorders.

Main Results:

• Metabolic epilepsies are treatable, leading to improved prognosis.
• Targeted interventions based on specific metabolic pathophysiology are effective.
• Early diagnosis and management significantly alter the disease course.

Conclusions:

• Knowledge of treatable metabolic epilepsies is crucial for pediatric neurologists.
• Timely diagnosis and specific metabolic interventions offer a significant opportunity to improve outcomes.
• Personalized treatment strategies are essential for managing severe pediatric epilepsy syndromes.